Screen-Printed Electrodes—A Promising Tool for Antineoplastic Drug Detection (Cisplatin and Bleomycin) in Biological Samples
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158030 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Andreea-Cristina Mirica Ion und 6 weiteren Autor:innen. Beteiligte Einrichtung: DDS Diagnostic, 032032 Bucharest, Romania. Hauptthemen laut MEDLINE: Bleomycin, Cisplatin, Biosensing Techniques, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Executive Agency for Higher Education, Research, Development, and Innovation Funding-UEFISCDI, DDS Diagnostic SRL, Executive Agency for Higher Education, Research, Development, and Innovation Funding–UEFISCDI.
Abstract (Originalsprache)
Cancer remains one of the leading causes for death worldwide. Palliative chemotherapy is vital for certain cancer patients, highlighting the critical need for treatment monitoring tools to prevent drug accumulation and mitigate the risk of high toxicity. Therefore, our aim was to evaluate the potential of screen-printed electrodes for the development of sensitive and accurate biosensors for the detection/quantification of antineoplastic drugs. To this purpose, we developed a cisplatin sensor. By functionalizing the gold electrode with human serum albumin and by collecting the electrochemical signal obtained in a H2O2 solution, through voltammetry measurements, we were able to correlate the current measured at 430 mV with the concentration of cisplatin present in human serum samples, with a correlation coefficient of R2 = 0.99. Also, a bleomycin biosensor was developed and proven functional, but further optimization steps were employed in order to improve the accuracy. The developed biosensors have a detection range of 0.0006–43.2 mg/mL for cisplatin and 0.23–7.56 μg/mL for bleomycin in the serum samples. Our preliminary results show that these biosensors can facilitate the real-time monitoring of cisplatin and bleomycin serum levels, allowing healthcare professionals to tailor treatment strategies based on individual patient responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- DDS Diagnostic, 032032 Bucharest, Romania.
- Advanced Polymer Materials Group, University Politehnica of Bucharest, 1-7 Gh. Polizu Street, 011061 Bucharest, Romania.
- Department of Pneumology I, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- National Institute for Research and Development in Microtechnologies (IMT Bucharest), 126A Erou Iancu Nicolae Street, 077190 Bucharest, Romania.
ORCID-Profile: Marioara Avram, Lorena-Andreea Bocancia-Mateescu
Förderung
- Executive Agency for Higher Education, Research, Development, and Innovation Funding-UEFISCDI
- DDS Diagnostic SRL
- Executive Agency for Higher Education, Research, Development, and Innovation Funding–UEFISCDI
Zitieren
APA
Mirica Ion, A. C., Stan, D., Zaharia, D. C., Iovu, H., Mocanu, S., Avram, M., & Bocancia-Mateescu, L. A. (2024). Screen-Printed Electrodes—A Promising Tool for Antineoplastic Drug Detection (Cisplatin and Bleomycin) in Biological Samples. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158030
Vancouver
Mirica Ion AC, Stan D, Zaharia DC, Iovu H, Mocanu S, Avram M, et al. Screen-Printed Electrodes—A Promising Tool for Antineoplastic Drug Detection (Cisplatin and Bleomycin) in Biological Samples. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158030
BibTeX
@article{MiricaIon2024,
author = {Mirica Ion, Andreea-Cristina and Stan, Dana and Zaharia, Dragos-Cosmin and Iovu, Horia and Mocanu, Sorin and Avram, Marioara and Bocancia-Mateescu, Lorena-Andreea},
title = {Screen-Printed Electrodes—A Promising Tool for Antineoplastic Drug Detection (Cisplatin and Bleomycin) in Biological Samples},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158030}
}
EUVIMED